Bank of Montreal’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-1,808
| Closed | -$463K | – | 4708 |
|
2021
Q1 | $463K | Sell |
1,808
-629
| -26% | -$161K | ﹤0.01% | 2350 |
|
2020
Q4 | $845K | Buy |
2,437
+128
| +6% | +$44.4K | ﹤0.01% | 1987 |
|
2020
Q3 | $581K | Sell |
2,309
-196
| -8% | -$49.3K | ﹤0.01% | 1941 |
|
2020
Q2 | $698K | Buy |
2,505
+164
| +7% | +$45.7K | ﹤0.01% | 1808 |
|
2020
Q1 | $379K | Buy |
2,341
+639
| +38% | +$103K | ﹤0.01% | 1877 |
|
2019
Q4 | $760K | Buy |
1,702
+1,610
| +1,750% | +$719K | ﹤0.01% | 2039 |
|
2019
Q3 | $28K | Buy |
92
+3
| +3% | +$913 | ﹤0.01% | 3409 |
|
2019
Q2 | $28K | Buy |
+89
| New | +$28K | ﹤0.01% | 3526 |
|
2018
Q3 | – | Sell |
-10
| Closed | -$4K | – | 4495 |
|
2018
Q2 | $4K | Sell |
10
-406
| -98% | -$162K | ﹤0.01% | 3862 |
|
2018
Q1 | $122K | Buy |
+416
| New | +$122K | ﹤0.01% | 2640 |
|
2017
Q1 | – | Sell |
-3
| Closed | -$1K | – | 3827 |
|
2016
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 3671 |
|
2015
Q3 | – | Sell |
-3
| Closed | -$2K | – | 3872 |
|
2015
Q2 | $2K | Sell |
3
-4
| -57% | -$2.67K | ﹤0.01% | 3539 |
|
2015
Q1 | $57K | Buy |
+7
| New | +$57K | ﹤0.01% | 2659 |
|
2014
Q3 | – | Hold |
0
| – | -$3K | – | 3941 |
|
2014
Q2 | – | Hold |
0
| – | – | – | 3974 |
|